LAUSANNE, Switzerland, Sept. 27, 2019 /PRNewswire/ — LigneSante today announced their newest addition to the planned development of MyClinic software. Success hinges upon understanding the patient population and communicating with them, especially as the healthcare system moves towards the value-based reimbursement system.
The public health is the science and art of preventing disease and disability, prolong life, and promote healthy physical and mental well-being through organized efforts of the community. They focus on the rehabilitation and development of the social machinery that will ensure each individual in the community an adequate standard of living for the maintenance of health.
“Public health is the science and art of preventing disease.” – Jayson Lux, Co-founder
Health Situation Analysis (ASIS) has been defined as analytical-synthetic processes that cover various types of analysis. They allow to characterize, measure and explain the health-disease profile of a population including the damages and health problems as well as their determinants, whether they are, the competence of the health sector or other sectors. The ASIS facilitate the identification of health needs and priorities, as well as the identification of appropriate interventions and programs and the evaluation of their impact on health.
LigneSante provides medical professionals with all the advantages of a sophisticated and user-friendly system. Our population health analytics will enable medical professionals to improve patient outcomes and expand market share with MyClinic. In particular, they can:
LigneSante will be available for a 90-day free trial. For more information visit https://lignesante.com/
About LigneSante: We are a community of medical professionals, sharing ideas, comparing notes, referring patients, and striving for an integrated approach of medicine. Ultimately for the betterment of humankind.
Jayson Lux
Lux Inbound
+41 78 664 76 71
jayson@luxinbound.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/luxinbound-lignesante-solving-big-picture-problems-through-population-health-300926849.html
SOURCE LuxInbound
RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on…
The funding will train 100 new employees at Wesley Pharmaceuticals, supporting local talent and healthcare…
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000…
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect…
MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer…
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology…